🇺🇸 FDA
Pipeline program

DEXAMETHASONE SODIUM PHOSPHATE, VELCADE 3.5 mg powder for solution for injection, DARATUMUMAB, CYCLOPHOSPHAMIDE

54767414AMY2009

Phase 2 small_molecule active

Quick answer

DEXAMETHASONE SODIUM PHOSPHATE, VELCADE 3.5 mg powder for solution for injection, DARATUMUMAB, CYCLOPHOSPHAMIDE for Amyloid Light Chain Amyloidosis is a Phase 2 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Janssen-Cilag International N.V.
Indication
Amyloid Light Chain Amyloidosis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials